Literature DB >> 28367859

Identification and Assessment of Cardiac Amyloidosis by Myocardial Strain Analysis of Cardiac Magnetic Resonance Imaging.

Seitaro Oda1, Daisuke Utsunomiya1, Takeshi Nakaura1, Hideaki Yuki1, Masafumi Kidoh1, Kosuke Morita2, Seiji Takashio3, Megumi Yamamuro3, Yasuhiro Izumiya3, Kyoko Hirakawa3, Toshifumi Ishida3, Kenichi Tsujita3, Mitsuharu Ueda4, Taro Yamashita4, Yukio Ando4, Hiroyuki Hata5, Yasuyuki Yamashita1.   

Abstract

BACKGROUND: We explored the usefulness of myocardial strain analysis on cardiac magnetic resonance imaging (CMR) scans for the identification of cardiac amyloidosis.Methods and 
Results: The 61 patients with systemic amyloidosis underwent 3.0-T CMR, including CMR tagging and late-gadolinium enhanced (LGE) imaging. The circumferential strain (CS) of LGE-positive and LGE-negative patients was measured on midventricular short-axis images and compared. Logistic regression modeling of CMR parameters was performed to detect patients with LGE-positive cardiac amyloidosis. Of the 61 patients with systemic amyloidosis 48 were LGE-positive and 13 were LGE-negative. The peak CS was significantly lower in the LGE-positive than in the LGE-negative patients (-9.5±2.3 vs. -13.3±1.4%, P<0.01). The variability in the peak CS time was significantly greater in the LGE-positive than in the LGE-negative patients (46.1±24.5 vs. 21.2±20.1 ms, P<0.01). The peak CS significantly correlated with clinical biomarkers. The sensitivity, specificity, and accuracy of the diagnostic model using CS parameters for the identification of LGE-positive amyloidosis were 93.8%, 76.9%, and 90.2%, respectively.
CONCLUSIONS: Myocardial strain analysis by CMR helped detect LGE-positive amyloidosis without the need for contrast medium. The peak CS and variability in the peak CS time may correlate with the severity of cardiac amyloid deposition and may be more sensitive than LGE imaging for the detection of early cardiac disease in patients with amyloidosis.

Entities:  

Keywords:  Cardiac amyloidosis; Cardiac magnetic resonance imaging; Late-gadolinium enhancement; Myocardial strain

Mesh:

Substances:

Year:  2017        PMID: 28367859     DOI: 10.1253/circj.CJ-16-1259

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  9 in total

Review 1.  Multidisciplinary Approaches for Transthyretin Amyloidosis.

Authors:  Haruki Koike; Takahiro Okumura; Toyoaki Murohara; Masahisa Katsuno
Journal:  Cardiol Ther       Date:  2021-06-04

2.  Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.

Authors:  Lynne K Williams; Julian F Forero; Zoran B Popovic; Dermot Phelan; Diego Delgado; Harry Rakowski; Bernd J Wintersperger; Paaladinesh Thavendiranathan
Journal:  J Cardiovasc Magn Reson       Date:  2017-08-07       Impact factor: 5.364

Review 3.  The Evolving Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Systemic Amyloidosis.

Authors:  Sanjay M Banypersad
Journal:  Magn Reson Insights       Date:  2019-05-01

4.  A multi-vendor, multi-center study on reproducibility and comparability of fast strain-encoded cardiovascular magnetic resonance imaging.

Authors:  Jennifer Erley; Victoria Zieschang; Tomas Lapinskas; Aylin Demir; Stephanie Wiesemann; Markus Haass; Nael F Osman; Orlando P Simonetti; Yingmin Liu; Amit R Patel; Victor Mor-Avi; Orhan Unal; Kevin M Johnson; Burkert Pieske; Jochen Hansmann; Jeanette Schulz-Menger; Sebastian Kelle
Journal:  Int J Cardiovasc Imaging       Date:  2020-02-13       Impact factor: 2.357

Review 5.  Multimodality Imaging in the Diagnosis and Assessment of Cardiac Amyloidosis.

Authors:  Jyothirmayi Velaga; Charlene Liew; Angeline Choo Choo Poh; Phong Teck Lee; Narayan Lath; Shoen Choon Low; Pushan Bharadwaj
Journal:  World J Nucl Med       Date:  2022-08-16

Review 6.  Multi-modality imaging in transthyretin amyloid cardiomyopathy.

Authors:  Bryan Paul Traynor; Aamir Shamsi; Victor Voon
Journal:  World J Cardiol       Date:  2019-11-26

Review 7.  The Role of Multi-modality Imaging in the Diagnosis of Cardiac Amyloidosis: A Focused Update.

Authors:  Shaun Khanna; Ivy Wen; Aditya Bhat; Henry H L Chen; Gary C H Gan; Faraz Pathan; Timothy C Tan
Journal:  Front Cardiovasc Med       Date:  2020-10-30

Review 8.  Diagnostic Work-Up of Cardiac Amyloidosis Using Cardiovascular Imaging: Current Standards and Practical Algorithms.

Authors:  Grigorios Korosoglou; Sorin Giusca; Florian André; Fabian Aus dem Siepen; Peter Nunninger; Arnt V Kristen; Norbert Frey
Journal:  Vasc Health Risk Manag       Date:  2021-10-23

Review 9.  Transthyretin cardiac amyloidosis: a review of the nuclear imaging findings with emphasis on the radiotracers mechanisms.

Authors:  Teodor M Ionescu; Wael Jalloul; Cati R Stolniceanu; Roxana Iacob; Laura P Grecu; Ana-Maria Stătescu; Irena Grierosu; Mihai Guțu; Adrian Gavrilescu; Crișu Daniela; Antoniu Petriș; Manuela Ciocoiu; Cristina Ungureanu; Cipriana Ștefănescu
Journal:  Ann Nucl Med       Date:  2021-07-17       Impact factor: 2.668

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.